Group 1 - The company has significantly increased its R&D investment in recent years, focusing on fields such as radiotherapy, minimally invasive endoscopy, and rehabilitation intelligent devices [1] - The company has achieved phased breakthroughs, resulting in the registration of multiple new products and international certifications [1] - The core competitiveness of the company is steadily improving as a result of these efforts [1]